Aytu BioPharma publishes in vitro data demonstrating UV-A light increases mitochondrial anti-viral signaling protein within cells
ENGLEWOOD, CO / May 17, 2021 / Aytu BioPharma, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products,…
More from InformationalMore posts in Informational »
- UV Business News – Aaon Annual Report 2023 Including Evaluation of Air Quality Products
- Cranbrook, CA Receives $9.5 M For New Phillips Reservoir UV Disinfection Facility
- Innovating Together: UV and the Fight for Cleaner Air
- UV Business News – Applied UV As A Major UVC Player Files Form 424B5 With The SEC – Prospectus For Sale of Common Shares and Pre-Funded Warrants
- Spainish Photovoltaic System Generates Energy And Disinfects Water Using Ultraviolet Light From Sun